Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
about
Transglutaminase is a tumor cell and cancer stem cell survival factorSmall molecule inhibitors target the tissue transglutaminase and fibronectin interactionβ-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroidsTransglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.Nuclear signaling from cadherin adhesion complexesTransglutaminase 2 as a novel activator of LRP6/β-catenin signaling.Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cellsCellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in OsteoblastsTransglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.Lack of transglutaminase 2 diminished T-cell responses in mice.Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche.Targeting the Microenvironment in High Grade Serous Ovarian Cancer
P2860
Q26799862-48092B89-26DC-4C54-BC3F-C109A1569467Q28540004-62EF451B-3A90-4359-880E-D16598FCD86FQ30370274-BA962584-E5E9-49DC-867F-04B3267511B8Q35053942-5439E02A-228D-485C-9BA5-F5DB5673CDC1Q35539061-54176B13-D6D4-47CA-9DA6-AE0FD040A68BQ37434321-ACA293FF-B0E1-4F25-981B-B9D86BBABE4DQ37684607-6E751B7B-14BA-4887-9CC2-6E84F44D9D30Q37694339-36178181-2DDD-4A3A-A043-31176471B8CEQ38715434-132A8F47-7AEE-47B8-ACF2-17BDFF5F2F77Q39657548-DFF45738-D6AB-4ACD-B507-6B9C8FA65FD3Q48305796-4B4DCE56-0602-4305-B474-E1379B08CD54Q50857431-27119F20-C997-41CA-9B63-263BCFD8E079Q52365303-E65A3A3F-CA79-49C1-89F2-E198C542308BQ58789499-0FC47128-1C7F-4AEC-9E4F-F97E3AFD4968
P2860
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@ast
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@en
type
label
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@ast
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@en
prefLabel
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@ast
Tissue transglutaminase regula ...... h a c-Src-dependent mechanism.
@en
P2860
P356
P1433
P1476
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism
@en
P2093
Salvatore Condello
P2860
P304
P356
10.1096/FJ.12-222620
P407
P577
2013-05-02T00:00:00Z